Leiden University Medical Center at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Leiden University Medical Center takes part in 4 sessions at ESMO 2026 in Madrid. Its sessions span breast cancer, lung cancer and drug policy. It presents results on omitting radiotherapy after breast-conserving surgery in older patients with early estrogen receptor-positive breast cancer, tumour-infiltrating lymphocyte therapy in advanced non-small cell lung cancer, and cancer drugs used more off-label than on-label.

OrganizationESMO 2026 Attendance
lumc.nl
Cancer centre & hospital
Academic hospital and medical faculty of Leiden University in Leiden, Netherlands.
Abstract
Fri Oct 23
17:19–17:24
Chair
Sat Oct 24
08:30–10:00
Rapid oral 1: NSCLC, metastatic
with Dana-Farber Cancer Institute, MD Anderson Cancer Center
Lung & thoracic cancers
Abstract
Sat Oct 24
09:32–09:44
Invited Discussant 2631RO and 2658RO
Rapid oral 1: NSCLC, metastatic
Lung & thoracic cancers
Abstract
Sun Oct 25
08:57–09:02
Abstract
Sun Oct 25
10:15–10:25

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Leiden University Medical Center

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction